1st Quarter - Report

GOVERNMENT COUNSEL, LLC for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General issues relating to oversight of PBM services, government negotiated drug pricing and Part D cost sharing; The Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (CMS‐4192‐P) Proposed Rule relating to pharmacy direct and indirect remuneration.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.